Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,239
Closed -$183K 329
2024
Q1
$183K Buy
17,239
+7,074
+70% +$70.8K 0.01% 353
2023
Q4
$122K Sell
10,165
-5,518
-35% -$45.2K 0.01% 298
2023
Q3
$110K Sell
15,683
-2,754
-15% -$25.4K 0.01% 280
2023
Q2
$157K Sell
18,437
-4,685
-20% -$39.1K 0.01% 287
2023
Q1
$211K Sell
23,122
-2,333
-9% -$29.8K 0.02% 289
2022
Q4
$290K Buy
25,455
+5,382
+27% +$79.8K 0.02% 238
2022
Q3
$342K Buy
20,073
+784
+4% +$16.8K 0.03% 214
2022
Q2
$414K Buy
19,289
+10,574
+121% +$293K 0.04% 183
2022
Q1
$322K Buy
+8,715
New +$340K 0.01% 178

Other funds holding CDNA

E Fund Management's CDNA Position: Q2 2024 in Review

E Fund Management sold out of CareDx (CDNA) in Q2 2024, closing a stake of 17,239 shares — an estimated $183K sold.

E Fund Management first reported a position in CDNA in Q1 2022 and held it in 9 quarters. The position peaked at $414K in Q2 2022. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2024.

  • E Fund Management reported no remaining CareDx position as of Q2 2024 after selling out during the quarter.
  • E Fund Management sold 17,239 CareDx shares in Q2 2024, an estimated $183K.
  • E Fund Management first reported a position in CareDx in Q1 2022 and held it in 9 quarters.
  • E Fund Management's CareDx position peaked at $414K in Q2 2022.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2024.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.